Combination Study for High Risk Multiple Myeloma Patients
Condition(s):Multiple MyelomaLast Updated:March 31, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:March 31, 2022Terminated
Condition(s):Multiple Myeloma; Relapse Multiple Myeloma; Refractory Multiple MyelomaLast Updated:December 9, 2021Recruiting
Condition(s):Multiple Myeloma in Relapse; Multiple Myeloma, RefractoryLast Updated:June 18, 2019Completed
Condition(s):MCL; Mantle Cell LymphomaLast Updated:February 12, 2024Active, not recruiting
Condition(s):Multiple Myeloma; MyelomaLast Updated:July 10, 2023Active, not recruiting
Condition(s):Exercise; Chemotherapy-induced PolyneuropathyLast Updated:June 1, 2020Completed
Condition(s):AL AmyloidosisLast Updated:September 22, 2020Completed
Condition(s):Myelodysplastic Syndrome (MDS); Infection; Risk Factors; IPSS High RiskLast Updated:December 21, 2016Unknown status
Condition(s):Follicular Lymphoma (FL)Last Updated:March 22, 2024Recruiting
Condition(s):Multiple Myeloma; Renal FailureLast Updated:December 13, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.